CareCloud (NASDAQ:CCLD – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.100-0.130 for the period, compared to the consensus estimate of -0.210. The company issued revenue guidance of $111.0 million-$114.0 million, compared to the consensus revenue estimate of $112.2 million.
Wall Street Analyst Weigh In
Several equities research analysts have commented on the company. Roth Capital lowered CareCloud from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Benchmark reissued a “buy” rating and issued a $4.50 price objective on shares of CareCloud in a research note on Friday, November 15th. Finally, Roth Mkm cut shares of CareCloud from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $5.00 to $3.50 in a research note on Wednesday, November 13th.
Read Our Latest Analysis on CareCloud
CareCloud Price Performance
CareCloud (NASDAQ:CCLD – Get Free Report) last announced its quarterly earnings data on Thursday, March 13th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). CareCloud had a negative net margin of 35.25% and a negative return on equity of 87.98%. On average, equities analysts anticipate that CareCloud will post 0.58 earnings per share for the current year.
CareCloud Company Profile
CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.
Read More
- Five stocks we like better than CareCloud
- Differences Between Momentum Investing and Long Term Investing
- Gold Rally vs. Oil Surge: Where Investors Are Betting Next
- What Investors Need to Know to Beat the Market
- Intel Stock Surges on New CEO – The Real Story Runs Deeper
- Top Biotech Stocks: Exploring Innovation Opportunities
- Market Overreacts, But Guidewire’s Growth Story Remains Strong
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.